Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels.
about
Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine reviewMelatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative DiseasesClinical management of sleep disturbances in Alzheimer's disease: current and emerging strategiesMelatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and MetabolismPreanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation'The clocks that time us'--circadian rhythms in neurodegenerative disordersSleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsMelatonin in Alzheimer's disease and other neurodegenerative disordersMelatonin and cortisol profiles in late midlife and their association with age-related changes in cognitionIdentification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatoninTherapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment.When melatonin gets on your nerves: its beneficial actions in experimental models of stroke.The human pineal gland and melatonin in aging and Alzheimer's disease.Preoperative CSF Melatonin Concentrations and the Occurrence of Delirium in Older Hip Fracture Patients: A Preliminary StudyConsequences of Circadian Disruption on Neurologic Health.Melatonin Therapy in Patients with Alzheimer's Disease.Role of melatonin in Alzheimer-like neurodegeneration.Beneficial effects of melatonin in experimental models of Alzheimer disease.Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.Therapeutic application of melatonin in mild cognitive impairment.Melatonin in Alzheimer's diseaseMelatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.Protective effect of melatonin on soluble Aβ1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus.A hypnic hypothesis of Alzheimer's disease.Does selection for short sleep duration explain human vulnerability to Alzheimer's disease?The role of mitochondria in brain aging and the effects of melatonin.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow-Robin perivascular spaces.Extrapineal melatonin: sources, regulation, and potential functions.Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Current Phase II investigational therapies for insomnia.The Synergistic Relationship between Alzheimer's Disease and Sleep Disorders: An Update.Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.Monoaminergic neuropathology in Alzheimer's disease.
P2860
Q24675909-10003A16-0B25-41EA-98B3-F477FEE4D47DQ26772733-608DD219-6EA1-403D-B100-E40928426419Q26772851-618FD796-BC97-470D-85CE-F5D62379D6EFQ26779025-2FE946F3-D08F-45BF-9FE3-72E284E5BF3CQ26801663-E65378C0-8D8E-4C3D-8AFD-BF4AA3B1E414Q26824646-DE8132D2-1EBE-4214-B306-C6F9BB77E19CQ27024779-F120CD74-0E42-482B-A7E1-A4DDEE9CB6B8Q28070156-266FCE88-E2DA-4F11-87C7-46B54FA16937Q28075345-C84612AC-E935-4A4D-AAA6-9295CB33101BQ28217483-C18DEAE9-A1D5-46AE-B251-6521095C4A7FQ28385283-8FC5B959-1C85-462C-9F14-936DD562FF1CQ33275047-CB92DB77-E4C8-4EAC-9302-2B1C752A25C1Q34074924-85A743B4-1FBD-4FDD-912C-CFB56367109BQ34358480-E2B3031C-4F2B-4D8F-9BD6-641A1CC65F1AQ34402151-BA77CBE2-51A7-4F07-88AF-8709C561FF58Q34416921-B4506D05-2547-42B1-A0B1-EBD60514B1EAQ35884023-515AA387-3DF6-4259-8DCD-019D1C89DD55Q36021253-63693DAE-DB04-438D-A5BE-C7C7DD1FC2DAQ36051556-0553717D-84A8-47E8-8E51-0C7734F8E202Q36218223-D38934A8-06C0-47DD-96CA-F890D78C5189Q36289339-319092C8-A376-4977-89B2-C7D89E531B61Q36335048-E7EE2A71-1B5F-47DE-B796-E14A2B0CA19FQ36346522-237A4312-D272-445A-905B-618378EEDBC7Q36367936-C3308732-4DCE-4873-BA49-927CDA0CE1DEQ36433222-9D17C1BF-7A00-4531-BC1D-DCB0D1E7093DQ36576496-D2990133-82D1-42FC-8F76-E4446A4B143FQ37091982-0EE7B7B6-7D68-4E8B-B3D8-3F20CFFB9118Q37097780-655F8D0A-1145-4B44-8AA9-832A3E651813Q37258281-2F6CD296-1BC2-4B3A-8292-C074C025CA64Q37446899-62209336-1665-4AAE-9C13-99CB69EADEFCQ37738358-C14F224D-171D-4376-8BCA-7BA6CB04FA73Q37848076-4F146C18-9988-4312-BF38-17ADA87DE495Q38022179-9CE58671-D779-4748-AAF6-E93C1AACA2C4Q38189661-B8F26E02-BADD-4B16-BA4F-AF7A06424863Q38189699-F79C7C1C-E587-4258-86A8-865DEDCDCA7EQ38253060-4FC4D0CC-C7A8-4404-B089-BA3DBFE380AEQ38271292-B467ADED-0136-4697-8156-FA699EA8F1CDQ38401859-E30E984E-F29D-4AFE-85CF-57DFF03109DCQ38476020-EB7D1F1B-78D7-4147-A266-E5B6F93DB133Q38809649-7E2E4F73-4AB0-4819-A7C3-62E302228900
P2860
Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@en
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@nl
type
label
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@en
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@nl
prefLabel
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@en
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@nl
P2093
P2860
P921
P1476
Early neuropathological Alzhei ...... spinal fluid melatonin levels.
@en
P2093
Jiang-Ning Zhou
Michel A Hofman
Rong-Yu Liu
Wouter Kamphorst
P2860
P304
P356
10.1034/J.1600-079X.2003.00065.X
P50
P577
2003-09-01T00:00:00Z